What Framework for Real-World Evidence Program Guidance 2018 requires
The FDA Real-World Evidence Program Guidance 2018 requires sponsors to submit real-world evidence (RWE) studies that meet specific standards for data sources, study design, and fit-for-purpose, as outlined in Section II of the guidance.
Pillar: Pharmaceuticals & Life Sciences · Authority: U.S. Food and Drug Administration · Version: 1.0.0 · Last updated:
Primary source: https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence
SHA-256 integrity: 16b9136c4baaacf00da86f9bdd8db3a6780ef63c0447afe073a8dba37cf690fa
Primary Citations — 7 traced to source
- Framework for Real-World Evidence Program Guidance 2018, Section II - Data Sources
- Framework for Real-World Evidence Program Guidance 2018, Section III - Study Design
+ 5 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/fda-real-world-evidence-program-guidance-2018.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/fda-real-world-evidence-program-guidance-2018.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/fda-real-world-evidence-program-guidance-2018
- Back to registry: Browse all 10,090 compliance nodes